36.80000 EUR
1.4
3.66%
Last update Dec 18, 7:37 PM CET
Market closed
Day range
36.80000
39.60000
Previous close
38.20000
Open
38
Access this stock data via API
Subscribe
Nektar Therapeutics Inc.
36.80
1.40
3.66%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 10.0M 9.5M 8.9M 24.9M
Cost of revenue 0 0 0 6.8M
Gross profit 10.0M 9.5M 8.9M 18.1M
Operating expense
Research & development 23.2M 25.5M 26.0M 24.5M
Selling general and admin 13.7M 14.5M 20.7M 14.6M
Other operating expenses
Operating income -26.9M -30.5M -37.8M -21.0M
Non operating interest income
Income 2.4M 1.7M 2.4M 2.5M
Expense 5.2M 4.6M 4.2M 8.7M
Other income expense -222.4K -159.4K 82.7K 33.1M
Pretax income -29.8M -33.6M -39.5M 6.0M
Tax provision -28.1K -160.2K 44.3K -220.7K
Net income -30.3M -35.4M -43.4M 6.2M
Basic EPS -1.9 -3.0 -3.6 0.5
Diluted EPS -1.9 -3.0 -3.6 0.5
Basic average shares 16.1M 12.0M 12.0M 11.9M
Diluted average shares 16.1M 12.0M 12.0M 12.1M
EBITDA -24.4M -28.4M -34.8M -18.4M
Net income from continuing op. -30.3M -35.4M -43.4M 6.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 8 hours 33 minutes

23:26
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).